Familial hypercholesterolemia mutations in the Middle Eastern and North African region

A need for a national registry

Mary Aderayo Bamimore, Ahmed Zaid, Yajnavalka Banerjee, Ahmad Al-Sarraf, Marianne Abifadel, Nabil G. Seidah, Khalid Al-Waili, Khalid Al-Rasadi, Zuhier Awan

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background Familial hypercholesterolemia (FH) is a well-understood Mendelian disorder that increases the risk of cardiovascular disease (CVD), a leading cause of mortality in Middle Eastern and North African (MENA) countries. Objective Review the reporting status of FH mutations across MENA and propose a systemic and strategic method for building a MENA FH registry. Methods Systematic literature search for statistics pertaining to CVD and comparison of number of FH mutations reported in MENA countries and countries with established FH registries. Results Only 57 mutations were reported in 17 MENA countries, whereas more than 500 mutations reported in 3 Western countries. Mortality rates due to CVD were significantly higher in MENA countries compared with Western countries. Conclusions The relatively low reporting of FH mutations in the consanguineous MENA communities with higher prevalence of CVD indicates poor awareness of CVD genetic risk and warrants a registry to prevent premature CVD due to FH. This registry will help in identifying novel and reported FH mutations, all of which will have clinical and research benefits in MENA countries.

Original languageEnglish
Pages (from-to)187-194
Number of pages8
JournalJournal of Clinical Lipidology
Volume9
Issue number2
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Hyperlipoproteinemia Type II
Registries
Mutation
Cardiovascular Diseases
Mortality
Research

Keywords

  • Cardiovascular diseases
  • Cascade testing
  • Familial hypercholesterolemia registry
  • Genetic screening
  • Mutations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Nutrition and Dietetics

Cite this

Familial hypercholesterolemia mutations in the Middle Eastern and North African region : A need for a national registry. / Bamimore, Mary Aderayo; Zaid, Ahmed; Banerjee, Yajnavalka; Al-Sarraf, Ahmad; Abifadel, Marianne; Seidah, Nabil G.; Al-Waili, Khalid; Al-Rasadi, Khalid; Awan, Zuhier.

In: Journal of Clinical Lipidology, Vol. 9, No. 2, 01.03.2015, p. 187-194.

Research output: Contribution to journalArticle

Bamimore, Mary Aderayo ; Zaid, Ahmed ; Banerjee, Yajnavalka ; Al-Sarraf, Ahmad ; Abifadel, Marianne ; Seidah, Nabil G. ; Al-Waili, Khalid ; Al-Rasadi, Khalid ; Awan, Zuhier. / Familial hypercholesterolemia mutations in the Middle Eastern and North African region : A need for a national registry. In: Journal of Clinical Lipidology. 2015 ; Vol. 9, No. 2. pp. 187-194.
@article{10cf494e77404fc3ba20933be60d4b8e,
title = "Familial hypercholesterolemia mutations in the Middle Eastern and North African region: A need for a national registry",
abstract = "Background Familial hypercholesterolemia (FH) is a well-understood Mendelian disorder that increases the risk of cardiovascular disease (CVD), a leading cause of mortality in Middle Eastern and North African (MENA) countries. Objective Review the reporting status of FH mutations across MENA and propose a systemic and strategic method for building a MENA FH registry. Methods Systematic literature search for statistics pertaining to CVD and comparison of number of FH mutations reported in MENA countries and countries with established FH registries. Results Only 57 mutations were reported in 17 MENA countries, whereas more than 500 mutations reported in 3 Western countries. Mortality rates due to CVD were significantly higher in MENA countries compared with Western countries. Conclusions The relatively low reporting of FH mutations in the consanguineous MENA communities with higher prevalence of CVD indicates poor awareness of CVD genetic risk and warrants a registry to prevent premature CVD due to FH. This registry will help in identifying novel and reported FH mutations, all of which will have clinical and research benefits in MENA countries.",
keywords = "Cardiovascular diseases, Cascade testing, Familial hypercholesterolemia registry, Genetic screening, Mutations",
author = "Bamimore, {Mary Aderayo} and Ahmed Zaid and Yajnavalka Banerjee and Ahmad Al-Sarraf and Marianne Abifadel and Seidah, {Nabil G.} and Khalid Al-Waili and Khalid Al-Rasadi and Zuhier Awan",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.jacl.2014.11.008",
language = "English",
volume = "9",
pages = "187--194",
journal = "Journal of Clinical Lipidology",
issn = "1933-2874",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Familial hypercholesterolemia mutations in the Middle Eastern and North African region

T2 - A need for a national registry

AU - Bamimore, Mary Aderayo

AU - Zaid, Ahmed

AU - Banerjee, Yajnavalka

AU - Al-Sarraf, Ahmad

AU - Abifadel, Marianne

AU - Seidah, Nabil G.

AU - Al-Waili, Khalid

AU - Al-Rasadi, Khalid

AU - Awan, Zuhier

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background Familial hypercholesterolemia (FH) is a well-understood Mendelian disorder that increases the risk of cardiovascular disease (CVD), a leading cause of mortality in Middle Eastern and North African (MENA) countries. Objective Review the reporting status of FH mutations across MENA and propose a systemic and strategic method for building a MENA FH registry. Methods Systematic literature search for statistics pertaining to CVD and comparison of number of FH mutations reported in MENA countries and countries with established FH registries. Results Only 57 mutations were reported in 17 MENA countries, whereas more than 500 mutations reported in 3 Western countries. Mortality rates due to CVD were significantly higher in MENA countries compared with Western countries. Conclusions The relatively low reporting of FH mutations in the consanguineous MENA communities with higher prevalence of CVD indicates poor awareness of CVD genetic risk and warrants a registry to prevent premature CVD due to FH. This registry will help in identifying novel and reported FH mutations, all of which will have clinical and research benefits in MENA countries.

AB - Background Familial hypercholesterolemia (FH) is a well-understood Mendelian disorder that increases the risk of cardiovascular disease (CVD), a leading cause of mortality in Middle Eastern and North African (MENA) countries. Objective Review the reporting status of FH mutations across MENA and propose a systemic and strategic method for building a MENA FH registry. Methods Systematic literature search for statistics pertaining to CVD and comparison of number of FH mutations reported in MENA countries and countries with established FH registries. Results Only 57 mutations were reported in 17 MENA countries, whereas more than 500 mutations reported in 3 Western countries. Mortality rates due to CVD were significantly higher in MENA countries compared with Western countries. Conclusions The relatively low reporting of FH mutations in the consanguineous MENA communities with higher prevalence of CVD indicates poor awareness of CVD genetic risk and warrants a registry to prevent premature CVD due to FH. This registry will help in identifying novel and reported FH mutations, all of which will have clinical and research benefits in MENA countries.

KW - Cardiovascular diseases

KW - Cascade testing

KW - Familial hypercholesterolemia registry

KW - Genetic screening

KW - Mutations

UR - http://www.scopus.com/inward/record.url?scp=84928824037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928824037&partnerID=8YFLogxK

U2 - 10.1016/j.jacl.2014.11.008

DO - 10.1016/j.jacl.2014.11.008

M3 - Article

VL - 9

SP - 187

EP - 194

JO - Journal of Clinical Lipidology

JF - Journal of Clinical Lipidology

SN - 1933-2874

IS - 2

ER -